Lattice Biologics (TSXV:LBL.H) Debt-to-Revenue : N/A (As of Jun. 2021)

Lattice Biologics Debt-to-Revenue Chart

Lattice Biologics Annual Data
	Trend	Dec10	Dec11	Dec12	Dec13	Dec14	Sep16	Sep17	Sep18	Sep19	Sep20
Debt-to-Revenue		Get a 7-Day Free Trial					0.75	0.88	1.76	0.97	1.27

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Debt-to-Revenue	Get a 7-Day Free Trial															1.49	0.99	1.73	-	N/A

Competitive Comparison of Lattice Biologics's Debt-to-Revenue

For the Medical Devices subindustry, Lattice Biologics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lattice Biologics's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Debt-to-Revenue falls into.

Lattice Biologics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Lattice Biologics's Debt-to-Revenue for the fiscal year that ended in Sep. 2020 is calculated as

Lattice Biologics's annualized Debt-to-Revenue for the quarter that ended in Jun. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2021) Revenue data.

Lattice Biologics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description